Method for producing 1,3-propanediol by fermentation of a recombinant microorganism

Abstract

Provided is a method for producing 1,3-propanediol by means of fermentation of a recombinant microorganism. First, a recombinant microorganism is provided; the recombinant microorganism can overexpress acetyl-CoA carboxylase genes: accBC and accDA, a malonyl-CoA synthetase gene: mcr, a 3-hydroxypropionyl-CoA synthetase gene: pcs, a 3-hydroxypropionyl-CoA reductase gene: pduP, and a 1,3-propanediol reductase gene: yqhD. The recombinant microorganism is subjected to fermentation culture in a flask or fermentor using glucose ad as raw material to obtain the 1,3-propanediol. The recombinant microorganism can utilize low-cost glucose, sucrose, molasses, xylose and the like as raw material in the fermentation process, without additional expensive vitamin B12. Thus, cost of the production is significantly reduced, and there is a promising prospect in market.

Description

RELATED APPLICATIONS

This application is a national stage application claiming priority from International Patent Application No. PCT/CN2018/095893, filed Jul. 17, 2018, which claims the benefit of CN Patent Application No. 201711405440.5, filed Dec. 22, 2017, the entire disclosures of which are incorporated herein by this reference.

SEQUENCE LISTING

The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy of the Sequence Listing, which was created on Oct. 19, 2020, is named NT012N-2020589.txt and is 18.0 kilobytes in size.

FIELD OF THE INVENTION

The invention relates to the field of genetic engineering or biological fermentation, in particular a method of efficiently bio-converting a fermentable carbohydrate to 1,3-propanediol by using a single recombinant microorganism without addition of vitamin B12.

PRIOR ART

1,3-propanediol, an important chemical raw material, may be used as an organic solvent in many industries, such as ink industry, printing and dyeing industry, painting industry, lubricant industry, and/or antifreeze industry. The main usage of 1,3-propanediol is that it can be used as a monomer for synthesizing polyester and polyurethane. In particular, 1,3-propanediol can be used to produce polytrimethylene terephthalate (PTT) by polymerizing with terephthalic acid. Compared with polyethylene terephthalate (PET), or polybutylene terephthalate (PBT), the PTT shows better performance in many aspects, such as better pollution resistance, toughness, re-bouncing and ultraviolet resistance, as well as wear resistance, low water absorption, and/or low static electricity. Thus, PTT is considered as an upgraded product of the PET, and has a promising prospect in commercial market.

At present, methods for producing 1,3-propanediol basically include chemical methods and biological methods. By the chemical methods, 1,3-propanediol can be synthesized through a complicated catalytic process by using propylene oxide or propylene as raw material. Disadvantages of the chemical methods include excessive by-products, poor selectivity, high temperature and pressure of operation condition, vast investment of equipments, and non-renewability of raw materials. Thus, the technical process adopting the chemical methods for producing 1,3-propanediol has been abandoned.

The biological methods for producing 1,3-propanediol include two main technical protocols: one is to produce 1,3-propanediol with a natural microorganism using glycerin as the raw material, and the other is to produce 1,3-propanediol with a recombinant microorganism by using glucose as the raw material. Both are described as below.

In one technical protocol, 1,3-propanediol is produced using glycerin as the raw material by a natural microorganism such as Klebsiella pneumoniae, Clostridium butyricum, or Citrobacter freundii which can convert glycerin into 1,3-propanediol under anaerobic or microaerobic conditions. The disadvantages of the technical protocol mainly include that: 1. a strict regulation on bio-safety is required during the production, because Klebsiella pneumoniae which is commonly employed is a conditioned pathogen; 2. the synthesis of many by-products, such as acetic acid, lactic acid, succinic acid and 2,3-butanediol renders later extraction processes very complicated; and 3. the price of glycerin fluctuates dramatically in commercial market.

There is another method in the prior art of producing 1,3-propanediol by using glucose as the raw material with a recombinant microorganism. For example, DuPont realizes one step conversion of glucose to 1,3-propanediol by exogenously expressing the glycerol synthesis pathway (the glycerol 3-phosphate dehydrogenase and the glycerol 3-phosphotase) from Saccharomyces cerevisiae as well as the glycerol dehydratase and its activating factors from Klebsiella pneumoniae in E. coli together with the NADPH-depended alcohol dehydrogenase, YqhD from E. coli (CN 200380104657.2). The disadvantage of this process is that the glycerol dehydratase requires the coenzyme B12 as co-factor which however cannot be synthesized by E. coli, so that the expensive vitamin B12 requires to be added during the fermentation, which dramatically increases the production cost and is not favorable for industrial and large-scale production.

DISCLOSURE OF THE INVENTION

The purpose of the invention is to provide a new method of directly converting a fermentable carbohydrate to 1,3-propanediol using a recombinant microorganism, which is of low cost and does not require the expensive vitamin B12 to be added.

Firstly, the invention provides a recombinant microorganism capable of overexpressing:

(1) the acetyl-CoA carboxylase genes accBC and accDA;

(2) the malonyl-CoA synthetase gene mcr;

(3) the 3-hydroxypropionyl-CoA synthetase gene pcs;

(4) the 3-hydroxypropionyl-CoA reductase gene pduP; and

(5) the 1,3-propanediol oxidoreductase gene yqhD.

A person skilled in the art will understand that: the microorganism according to the invention may be conventional model microorganisms, including but not limited to E. coli, Corynebacterium glutamicum, Bacillus subtilis, or Saccharomyces cerevisiae.

The recombinant microorganism according to the invention can express the acetyl-CoA carboxylase genes accBC and accDA, whose nucleotide sequences are set forth in SEQ ID Nos: 1 and 2, respectively.

In the examples of the invention, the acetyl-CoA carboxylase genes accBC and accDA are from Corynebacterium glutamicum.

Further, the recombinant microorganism according to the invention can express the malonyl-CoA synthetase gene mcr whose nucleotide sequence is set forth in SEQ ID NO: 3. In the examples of the invention, the malonyl-CoA synthetase gene mcr is from Chloroflexus aurantiacus.

Furthermore, the recombinant microorganism according to the invention can express the 3-hydroxypropionyl-CoA synthetase gene pcs, the 3-hydroxypropionyl-CoA reductase gene pduP, and the 1,3-propanediol oxidoreductase gene yqhD. In the examples of the invention, the 3-hydroxypropionyl-CoA synthetase gene pcs is from Metallosphaera sedula, whose nucleotide sequence is set forth in SEQ ID NO: 4; the 3-hydroxypropionyl-CoA reductase gene pduP is from Klebsiella pneumoniae, whose nucleotide sequence is set forth in SEQ ID NO: 5; and the 1,3-propanediol oxidoreductase gene yqhD is from E. coli, whose nucleotide sequence is set forth in SEQ ID NO: 6. A person skilled in the art will understand that the description is not limited to the enzymes of the strains in the examples, and that any enzyme from other sources which shows the same function can also achieve the same the technical effects.

In the examples of the invention, the recombinant microorganism was obtained by the following processes:

• • (1) linking the gene accBC the sequence of which is set forth in SEQ ID NO: 1, and the gene accDA the sequence of which is set forth in SEQ ID NO: 2 to the plasmid pACYCDuet, to obtain the recombinant plasmid pACYC-accDABC;
  • (2) linking the mcr fragment of 3.7 kb obtained by PCR amplification using the nucleotide sequence of SEQ ID NO: 3 as a template, with the primers set forth in SEQ ID NOs: 11-12, to the plasmid pACYC-accDABC, to obtain the recombinant plasmid pACYC-accDABC-mcr, and then transforming this recombinant plasmid into E. coli to obtain the recombinant strain, E. coli/pACYC-accDABC-mcr after screening;
  • (3) linking the pcs fragment of 2.0 kb obtained by PCR amplification using the nucleotide sequence of SEQ ID NO: 4 as a template, with the primers set forth in SEQ ID NOs:13-14, the pduP fragment of SEQ ID NO: 5, and the yqhD fragment of SEQ ID NO: 6 to the plasmid pET28, to obtain the recombinant plasmid pET-pcs-pduP-yqhD;
  • (4) transforming the pET-pcs-pduP-yqhD into the recombinant strain E. coli/pACYC-accDABC-mcr obtained in the step (2), to obtain the recombinant strain E. coli/pACYC-accDABC-mcr/pET-pcs-pduP-yqhD after screening, which is the recombinant microorganism according to the invention.

The invention provides use of the recombinant microorganism in the production of 1,3-propanediol.

The invention provides a method of producing 1,3-propanediol by fermentation with the recombinant microorganism, comprising the steps of:

• • (1) constructing the recombinant microorganism capable of overexpressing the acetyl-CoA carboxylase genes accBC and accDA, the malonyl-CoA synthetase gene mcr, the 3-hydroxypropionyl-CoA synthetase gene pcs, the 3-hydroxypropionyl-CoA reductase gene pduP, and the 1,3-propanediol oxidoreductase gene yqhD; and
  • (2) conducting an aerobic fermentation using a raw material comprising a fermentable carbohydrate as the substrate and without the need of adding the vitamin B12.

The raw material comprising a fermentable carbohydrate in the step (2) is molasses, sucrose, glucose, starch hydrolysate, corn syrup, xylose, mannose, or glycerin.

The conditions for fermentation in the step (2) are: 28° C. to 37° C., a pH value in a range from 5 to 8, and a dissolved oxygen value greater than 10%.

Preferably, the fermentation conditions in the step (2) are: 30° C. to 37° C., a pH value in a range from 6 to 7, and the dissolved oxygen value greater than 10%.

The substrate for fermentation in the step (2) further comprises Na₂HPO₄, KH₂PO₄, MgSO₄, NaCl, yeast extract, NH₄Cl, thiamine hydrochloride, and biotin.

The invention proposed a synthesis pathway of 1,3-propanediol as shown in FIG. 1: firstly, the acetyl-CoA is generated from glucose (or another fermentable carbohydrate) through the glycolysis pathway in the microorganism itself; the acetyl-CoA generates the malonyl-CoA under the catalysis of the acetyl-CoA carboxylase; the malonyl-CoA generates malonate semialdehyde under the catalysis of the malonyl-CoA reductase; the malonate semialdehyde produces 3-hydroxypropionate under the catalysis of the malonate semialdehyde reductase; the 3-hydroxypropionate produces the 3-hydroxypropionyl CoA under the catalysis of the 3-hydroxypropionyl coenzyme A synthase; the 3-hydroxypropionyl CoA produces 3-hydroxypropanal under the catalysis of the 3-hydroxypropionyl CoA reductase; and the 3-hydroxypropanal produces 1,3-propanediol under the catalysis of the 1,3-propanediol oxidoreductase.

According to the invention, 1,3-propanediol is produced through fermentation in a flask or a fermenter using glucose as substrate, by a recombinant microorganism capable of overexpressing the acetyl-CoA carboxylase genes accBC and accDA, the malonyl-CoA synthetase gene mcr, the 3-hydroxypropionyl-CoA synthetase gene pcs, the 3-hydroxypropionyl-CoA reductase gene pduP, and the 1,3-propanediol oxidoreductase gene yqhD. During the fermentation process, the recombinant microorganism according to the invention can use the cheap glucose as the raw material without the need of adding the expensive vitamin B12, which could lower production cost dramatically, and has a promising prospect in commercial market. The method according to the invention is simplified, of low cost, produces a high yield of 1,3-propanediol with fewer by-products, and is beneficial for simplifying the separation of 1,3-propanediol.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a flowchart relating to the method for producing 1,3-propanediol using glucose by fermentation with a recombinant microorganism according to the invention.

DETAILED DESCRIPTION OF THE INVENTION

The examples below are only used to illustrate the invention, but not intended to limit the scope of the invention. Without deviating the spirit and essence of the invention, any amendment and replacement with respect to the method, step or condition of the invention also fall within the scope of the invention.

Unless indicated otherwise, chemical reagents used in the examples are conventional commercially available, and techniques used in the examples are conventional to a person skilled in the art.

Example 1

Construction of a recombinant plasmid for overexpressing the acetyl-CoA carboxylase genes accBC and accDA.

The gene accBC (the nucleotide sequence of which is set forth in SEQ ID NO: 1) of about 1.8 Kb was obtained by PCR amplification using the genome of Corynebacterium glutamicum ATCC 13032 as a template, with the primers accBC-F (tagcgcagtaaAAGGAGATATACCatgt cagtcgagactaggaaga) and accBC-R (CTGCAGGCGCGCCGAGCTCGttacttgatctcgaggagaaca acgcc) and purified.

The gene accDA (the nucleotide sequence of which is set forth in SEQ ID NO: 2) of about 1.5 kb was obtained by PCR amplification using the genome of Corynebacterium glutamicum ATCC 13032 as a template, with the primers accDA-F (GTTTAACTTTAATAAGGAGATA TACatggtgtggggcatggaac) and accDA-R (TATATCTCCTTttactgcgctaaacgctcaaatcg) and purified. The plasmid pACYCDuet (Novagen) was cleaved with Ncol and EcoRI; and the purified accBC and accDA fragments were one-step linked into the pACYCDuet by using the Gibson Assembly Kit (NEB), to obtain a recombinant plasmid designated as pACYC-accDABC.

Example 2

Construction of a recombinant plasmid for overexpressing the malonyl-CoA synthetase gene mcr.

Based on the amino acid sequence of the malonyl-CoA synthetase from Chloroflexus aurantiacus, an optimized nucleic acid sequence of the gene was artificially designed (the gene sequence is set forth in SEQ ID NO: 3) and synthesized by the Qinglan Biotech. Inc. A mcr fragment of about 3.7 kb was obtained by PCR using the gene fragment as a template with the primers mcr-F (GCGATCGCTGACGTCGGTACAAGGAGATATACATATGTCGGGC ACTG) and mcr-R (TTTACCAGACTCGAGGGTACTTAAACGGTGATTGCGCGTCC), and purified. The plasmid pACYC-accDABC prepared in the example 1 was cleaved with Kpnl, the mcr fragment was one-step linked to the pACYC-accDABC using the Gibson Assembly Kit (NEB), to obtain the recombinant plasmid pACYC-accDABC-mcr. After transforming the pACYC-accDABC-mcr into E. coli BL21 (DE3) by thermal transformation, a recombinant microorganism was selected in a LB plate containing chloramphenicol of 25 mg/L, which was designated as E. coli/pACYC-accDABC-mcr.

Example 3

Construction of a recombinant plasmid for overexpressing the 3-hydroxypropionyl-CoA synthetase gene pcs, the 3-hydroxypropionyl-CoA reductase gene pduP, and the 1,3-propanediol oxidoreductase gene yqhD.

Based on the amino acid sequence of the 3-hydroxypropionyl-CoA synthetase from Metallosphaera sedula, an optimized nucleic acid sequence of the gene was artificially designed (the gene sequence is set forth in SEQ ID NO: 4) and synthesized by the Qinglan Biotech. Inc. A pcs fragment of about 2.0 kb was obtained by PCR using the gene fragment as a template, with the primers pcs-F (CTTTAAGAAGGAGATATACCaggaggaaacagaaccATG TTTATGCGC) and pcs-R (acgttaatggTTAGGAAGTCTTTAATTCCTTCTTCAGTTCTTCC AC) and purified. A pduP gene of about 1.5 kb (the nucleotide sequence of which is set forth in SEQ ID NO: 5) was obtained by PCR using the genome of Klebsiella pneumoniae DSM2026 as a template, with the primers pduP-F (GACTTCCTAAccattaacgtgagaa ctcatcaatgaatacag) and pduP-R (atATGTATATCTCCTTCTTAAAGTTttagcgaatggaaaaaccgtt ggt), and purified. A yqhD gene of about 1.2 kb (the nucleotide sequence of which is set forth in SEQ ID NO: 6) was obtained by PCR using the genome of E. coli W3110 as a template, with the primers yqhD-F (TAAGAAGGAGATATACATatgAACAACTTTAATCTGCACACC) and yqhD-R (CAAGCTTGTCGACGGAGCTCGCGGGCGGCTTCGTATATACG), and purified. The plasmid pET32a (Novagen) was cleaved with Ncol and EcoRI, and the pcs fragment, the pduP fragment and the yqhD fragment were one-step linked into the pET28a to obtain a recombinant plasmid designated as pET-pcs-pduP-yqhD. After transforming the pET-pcs-pduP-yqhD into the E. coli/pACYC-accDABC-mcr obtained in the example 2 by thermal transformation, a recombinant microorganism was selected in a LB plate with Kanamycin at 25 mg/L and chloramphenicol at 25 mg/L, designated as E. coli/pACYC-accDABC-mcr/pET-pcs-pduP-yqhD.

Example 4

Production of 1,3-propanediol by fermentation with the recombinant E. coli

After culturing the E. coli/pACYC-accDABC-mcr/pET-pcs-pduP-yqhD obtained in the example 3 in a LB plate with Kanamycin (25 mg/L) and chloramphenicol (25 mg/L) overnight, a single colony from this fresh plate was inoculated to a 250 ml flask with baffle containing 30 ml seed culture medium, and incubated for 16 h at 30° C. and 200 rpm.

The composition of the seed culture medium comprises (g/L): glucose of 20, yeast extract of 5.0, peptone of 10, NaCl of 5.0, chloramphenicol of 0.025, and kanamycin of 0.025.

The seed broth was inoculated to a 1000 ml flask with baffle containing 100 ml fermentation culture medium at an inoculation amount of 10%, and incubated at 30° C. and 200 rpm. IPTG (0.5 mM) was added 6 hours after fermentation for induction and the fermentation were conducted for another 48 h.

The composition of the fermentation culture medium comprises (g/L): glucose of 20, Na₂HPO₄.7H₂O of 12.8, K₂HPO₄ of 3.0, MgSO₄ of 0.5, NaCl of 0.5, NH₄Cl of 0.5, yeast extract of 10, biotin of 0.001, thiamine hydrochloride of 0.001, chloramphenicol of 0.025, and Kanamycin of 0.025.

The E. coli/pACYC-accDABC-mcr/pET-pcs-pduP-yqhD obtained in the example 3 was detected at 24 h after fermentation for the enzyme activities of the acetyl-CoA carboxylase, malonyl-CoA synthetase, 3-hydroxypropionyl-CoA synthetase, 3-hydroxypropionyl-CoA reductase and 1,3-propanediol oxidoreductase, which were 0.24 U/mg, 0.12 U/mg, 0.38 U/mg, 0.97 U/mg and 1.72 U/mg, respectively, indicating that each of the recombinant enzymes was expressed normally. Substantially no corresponding enzyme activities were detected in the control wildtype E. coli BL21 (DE3).

At 48 h after the fermentation, the E. coli/pACYC-accDABC-mcr/pET-pcs-pduP-yqhD obtained in the example 3 could produce 1,3-propanediol at 2.1 g/L, with a mass conversion rate of 0.105 g/g of glucose, showing that the constructed recombinant strain can convert glucose to 1,3-propanediol directly, without addition of the coenzyme B12. In the control experiment under the same conditions, both the wildtype E. coli BL21 (DE3) and the E. coli/pACYC-accDABC-mcr obtained in the example 2 could not produce 1,3-propanediol.

Although the general description and the embodiments above have described the invention in detail, it is apparent for a person skilled in the art to make modification or alteration to them based on the disclosure of the invention. Thus, such modification and alteration without departure of the spirit of the invention fall within the scope of the invention.

Claims

1. A recombinant microorganism, characterized in that the recombinant microorganism is capable of overexpressing: (1) the acetyl-CoA carboxylase genes accBC and accDA;(2) the malonyl-CoA synthetase gene mcr;(3) the 3-hydroxypropionyl-CoA synthetase gene pcs;(4) the 3-hydroxypropionyl-CoA reductase gene pduP; and(5) the 1,3-propanediol oxidoreductase gene yqhD;wherein the nucleotide sequence of the 3-hydroxypropionyl-CoA synthetase gene pcs is set forth in SEQ ID NO: 4, and the nucleotide sequence of the 3-hydroxypropionyl-CoA reductase gene pduP is set forth in SEQ ID NO: 5.

2. The recombinant microorganism according to claim 1, characterized in that it is E. coli, Corynebacterium glutamicum, Bacillus subtilis, or Saccharomyces cerevisiae.

3. The recombinant microorganism according to claim 1, characterized in that the nucleotide sequences of the accBC and accDA are set forth in SEQ ID NOs: 1-2.

4. The recombinant microorganism according to claim 1, characterized in that the nucleotide sequence of the malonyl-CoA synthetase gene mcr is set forth in SEQ ID NO: 3.

5. The recombinant microorganism according to claim 1, characterized in that the nucleotide sequence of the 1,3-propanediol oxidoreductase gene yqhD is set forth in SEQ ID NO: 6.

6. Use of the recombinant microorganism according to claim 1 in the production of 1,3-propanediol by fermentation with a carbohydrate.

7. A method of producing 1,3-propanediol by using the recombinant microorganism according to claim 1, characterized in that it comprises steps of: (1) constructing a recombinant microorganism capable of overexpressing the acetyl-CoA carboxylase genes accBC and accDA, the malonyl-CoA synthetase gene mcr, the 3-hydroxypropionyl-CoA synthetase gene pcs, the 3-hydroxypropionyl-CoA reductase gene pduP and the 1,3-propanediol oxidoreductase gene yqhD; and(2) conducting an aerobic fermentation by using a raw material comprising a fermentable carbohydrate as substrate, without the need of adding coenzyme vitamin B12.

8. The method according to claim 7, characterized in that the raw material comprising a fermentable carbohydrate in the step (2) is molasses, sucrose, glucose, starch hydrolysate, corn syrup, xylose, mannose or glycerin; and conditions for fermentation are: 28° C. to 37° C., a pH value in a range from 5 to 8, and a dissolved oxygen value greater than 10%.